A randomised, controlled trial to compare the effects of systemic HRT [hormone replacement therapy] (tibolone) and vaginal oestrogen (estring) [estradiol] upon the overactive bladder in postmenopausal women

Trial Profile

A randomised, controlled trial to compare the effects of systemic HRT [hormone replacement therapy] (tibolone) and vaginal oestrogen (estring) [estradiol] upon the overactive bladder in postmenopausal women

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Mar 2016

At a glance

  • Drugs Estradiol (Primary) ; Tibolone (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jul 2009 Actual end date (Sep 2005) added as reported by ISRCTN: Current Controlled Trials.
    • 19 Aug 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top